home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

7.690 -0.250 (-3.15%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

17 18 Next >

Bull of the Day - NeoGenomics ↗

January 12, 2024

But in late December, shares took a big hit on patent litigation with competitor Natera. Let's review the primary commercial business of NEO and then that will help put the legal news into context.

Via Talk Markets

Topics Intellectual Property

ROSEN, A LEADING NATIONAL FIRM, Encourages NeoGenomics, Inc. Investors to Inquire About Securities Class Action Investigation – NEO

January 02, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

January 02, 2024

From NeoGenomics, Inc.

Via Business Wire

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

December 29, 2023

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.

Via Benzinga

7 Analysts Have This To Say About NeoGenomics ↗

December 28, 2023

Via Benzinga

What 6 Analyst Ratings Have To Say About NeoGenomics ↗

November 07, 2023

Via Benzinga

NeoGenomics Reports Third Quarter 2023 Results

November 06, 2023

Via ACCESSWIRE

Earnings Scheduled For November 6, 2023 ↗

November 06, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.

Via Benzinga

Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday ↗

December 29, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 28, 2023

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.

Via Benzinga

US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit ↗

December 28, 2023

Shares of NeoGenomics Inc (NASDAQ: NEO) fell Thursday after the company received a preliminary injunction from a North Carolina district court, which prohibits the company from

Via Benzinga

Where NeoGenomics Stands With Analysts ↗

October 16, 2023

Via Benzinga

4 Analysts Have This to Say About NeoGenomics ↗

August 21, 2023

Via Benzinga

NeoGenomics Raises Annual Guidance After Solid Q2 Earnings Beat ↗

August 08, 2023

NeoGenomics, Inc. (NASDAQ: NEO) reported Q2 revenues of $146.92 million, +18% Y/Y, beating the

Via Benzinga

Stocks Edge Higher As End Of 2023 Approaches ↗

December 28, 2023

The SPX is less than 10 points away from record close territory, and with one day left, all three major indexes are heading toward sizable December wins.

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 28, 2023

Via Benzinga

NeoGenomics, Energy Fuels And Other Big Stocks Moving Lower On Thursday ↗

December 28, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 80 points on Thursday. Shares of NeoGenomics, Inc. (NASDAQ: NEO) shares fell sharply during Thursday’s session after Natera won a...

Via Benzinga

Topics Intellectual Property Lawsuit Stocks

NeoGenomics to Appeal Ruling

December 28, 2023

Via ACCESSWIRE

NeoGenomics Reports Second Quarter 2023 Results

August 08, 2023

Via ACCESSWIRE

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response

December 05, 2023

Via ACCESSWIRE

NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference

November 14, 2023

Via ACCESSWIRE

Bull Of The Day: NeoGenomics ↗

October 24, 2023

NeoGenomics is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer.

Via Talk Markets

NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios

October 24, 2023

Via ACCESSWIRE

NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023

October 17, 2023

Via ACCESSWIRE

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

October 17, 2023

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END

Via FinancialNewsMedia

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 08, 2023

Via Benzinga

Earnings Scheduled For August 11, 2023 ↗

August 11, 2023

Companies Reporting Before The Bell • Consolidated Water Co (NASDAQ:CWCO) is estimated to report quarterly earnings at $0.22 per share on revenue of $30.27 million.

Via Benzinga

NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer

July 27, 2023

Via ACCESSWIRE

NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023

July 18, 2023

Via ACCESSWIRE

NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors

June 29, 2023

Via ACCESSWIRE

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com